Rosacea fulminans is a rare disease of unknown cause which occurs exclusively in women well past adolescence. It was previously called pyoderma faciale because of its confinement to the face covering most of the surface with innumerable fluctuant inflammatory nodules and papules which frequently fuse and form monstrosities. Seborrhea prior to onset is typical. It is not a pyoderma; neither it is infectious or a variant of acne conglobata. The patients respond well to a therapeutic regimen including isotretinoin in combination with topical and systemic corticosteroids. The response is superior and much more rapid than in patients treated with oral antibiotics. Rosacea fulminans is the only indication for topical or systemic corticosteroids in the treatment of rosacea. Scarring is often minimal when the lesions clear. No recurrence is seen.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.